Also known as Gilenya
Fingolimod (rINN, trade name Gilenya, Novartis) is an immunomodulating drug, approved for treating multiple sclerosis. It has reduced the rate of relapses in relapsing-remitting multiple sclerosis by over half. Fingolimod is a sphingosine 1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.Source: Wikipedia
Estimated Total Cost: $3799.41 for an average of 28 days supply
Patients are most commonly prescribed fingolimod to treat rabies, blastomycosis, west nile virus, and pick disease.